| Literature DB >> 23919095 |
Antonio Royo1, Maria Luisa Bertrand, Laura Ramos, Fernando Fernandez-Gordillo, Enrique Guerado.
Abstract
In recent decades, many technical improvements have been achieved in the use of prosthetic joints, and the risk of infection has been greatly reduced, to current rates of 0.4-2.0% following primary knee replacement. However, the increasing rate of joint replacements being performed means that the absolute number of such infections remains significant and poses substantial costs to healthcare systems worldwide. Accordingly, further strategies to treat and prevent total joint infections should be investigated. Infections following knee replacements can compromise the function and durability of arthroplasty. When these infections occur during the immediate postoperative period, irrigation and debridement with component retention can be attempted to salvage the implant. This is an attractive, cheap, low-morbidity treatment for periprosthetic knee infection. However, the results published regarding this procedure are uneven; some studies report the eradication of prosthetic joint infection by debridement alone in 70-90% of cases but conversely, others have reported a high failure rate for this procedure, averaging 68% (61-82%). The difference could be attributed in part to the multiplicity of variables that may influence the success of the procedure. One such is that of treatment with a continuous irrigation system, which has the theoretical advantage of enabling the administration of antimicrobial agents, as well as the drainage of debris and blood clots. The objective of this study is to elucidate the overall efficacy of irrigation and debridement with prosthesis retention in infected total knee arthroplasty and to determine whether the addition of a continuous irrigation system influences this efficacy.Entities:
Keywords: Total knee arthroplasty; continuous irrigation.; irrigation and debridement; periprosthetic infection
Year: 2013 PMID: 23919095 PMCID: PMC3731809 DOI: 10.2174/1874325001307010205
Source DB: PubMed Journal: Open Orthop J ISSN: 1874-3250
Comparison of Baseline Characteristics and Initial Infection Control Between Both Treatment Groups
| Variable | Continuous Closed Irrigation System (CCIS) (N=20) Number (%) | Debridement (ID) (N=14) Number (%) | p-Value ( Fisher Exact Test ) |
|---|---|---|---|
| Gender | |||
| Female | 13 (65) | 11 (78.6) | 0.467 |
| Male | 7 (35) | 3 (21.4) | |
| Charlson Comorbidity Index | |||
| Low Comorbidity (1 or 2 points) | 12 (60) | 4 (28.6) | 0.92 |
| High Comorbidity (>3 points) | 8 (40) | 10 (71.4) | |
| Diabetes Mellitus | |||
| Yes | 2 (10) | 2 (14.3) | 1 |
| No | 18 (90) | 12 (85.7) | |
| Rheumatoid arthritis | |||
| Yes | 2 (10) | 0 (0) | 0.501 |
| No | 18 (90) | 14 (100) | |
| Infected revision arthroplasty | |||
| Yes | 5 (25) | 2 (14.3) | 0.672 |
| No | 15 (75) | 12 (85.7) | |
| Type of Infection | |||
| Early Postoperative | 17 (85) | 13 (92.9) | 0.627 |
| Acute Haematogenous | 3 (15) | 1 (7.1) | |
| Microorganism: Staphylococcus Areus | |||
| Yes | 7 (35) | 5 (35.7) | 1 |
| No | 13 (65) | 9 (64.3) | |
| Number of microorganisms | |||
| Polybacterial | 6 (30) | 3 (21.4) | 0.704 |
| Monobacterial | 14 (70) | 11 (78.6) | |
| ASA Score | |||
| I and II | 9 (45) | 8 (57.1) | 0.728 |
| III and IV | 11 (55) | 6 (42.9) | |
| Purulence around prosthesis | |||
| Yes | 8 (40) | 1 (7.1) | 0.50 |
| No | 12 (60) | 13 (92.9) | |
| Polyethylene exchange | |||
| Yes | 4 (20) | 13 (92.9) | 0.379 |
| No | 16 (80) | 1 (7.1) | |
| Multiple debridements | |||
| Yes | 8 (40) | 3 (21.4) | 0.562 |
| No | 12 (60) | 11 (78.6) | |
| Infection control outcome | |||
| Controlled | 15 (75) | 10 (71.4) | 1 |
| Not Controlled | 5 (25) | 4 (28.6) | |
Age of Patients, Duration of Symptons, Hospital Length of Stay, Number of Additional Operations After Irrigation and Debridement and Treatment Duration for Both Treatment Groups
| Variable | Continuous Closed Irrigation System (CCIS) Median (and Interquartile Range) | Debridement (ID) Mean (and Interquartile Range) | p-Value (Mann-Whitney U Test) |
|---|---|---|---|
| Age | 68 (11.75) | 72.5 (7.5) | 0.188 |
| Duration of symptoms (days) | 3 (6.75) | 5.5 (13) | 0.507 |
| Hospital length of stay | 22 (13.75) | 9 (9) | 0.000 |
| Number of interventions | 1 (1) | 1 (1) | 0.671 |
| Follow up time (months) | 44 (73.25) | 40.5 (41.5) | 0.930 |
Statistically significant difference.